TheProductLawyers.com reports that a lawsuit was filed by a Texas couple in the Eastern District of New York. The lawsuit, filed under case number 1:14-cv-04524, was filed before being transferred to a multidistrict litigation (MDL 2592) consolidation in Eastern Louisiana after a decision handed down by the U.S. Judicial Panel on Multidistrict Litigation (JPML). The plaintiffs in this particular case have alleged that the defendants in the case, Bayer AG and Janssen Pharmaceuticals, the latter of which is a subsidiary of the Johnson and Johnson Corporation, failed to sufficiently warn patients and medical professionals of the life-threatening risks related to the use of Xarelto, the anticoagulant medication they were taking.
The female plaintiff alleges to have only used the drug for about 5 months when she suffered a very quick onset of internal bleeding. She was prescribed Xarelto by her doctor to treat her atrial fibrillation and to prevent against the risk of stroke, as she was told her medical condition left her susceptible to having a stroke. The plaintiff has also stated in her court filing paperwork that she still has issues with bleeding that have created some enduring medical problems.
Xarelto has been on the market for approximately 5 years. During that time it has become the focus of numerous lawsuits all across the United States. The drug was very popular with patients since it offered some benefits that blood thinner medications before it could not provide. Today, however, controversy swirls about the drug, as over 3,400 lawsuits have been filed. These lawsuits focus on the same allegations, that Xarelto puts patients at an increased risk for very dangerous, life-threatening internal bleeding that can be uncontrollable and fatal.
Complaints about the anticoagulant medication Xarelto and the risks associated with it continue to increase as many of the current plaintiffs await their court dates.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.
TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.
165 West End Ave #1h,
New York, NY 10023
November 30, 2016 – Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb
November 30, 2016 – Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings
November 30, 2016 – J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit
November 30, 2016 – Delaware Sees 10 New Talcum Powder Lawsuit Filings
November 29, 2016 – Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed
November 29, 2016 – Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother
November 29, 2016 – Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue
November 28, 2016 – FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings
November 28, 2016 – Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings
November 28, 2016 – More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts